Core Viewpoint - Argus Research raised the target price for U.S. Bancorp from $52 to $62, citing factors such as declining interest rates, stable credit quality, and strict cost control, which are expected to lead to stronger loan growth [1] Summary by Categories Target Price Adjustment - The target price for U.S. Bancorp has been increased from $52 to $62 [1] Earnings Forecast - Argus has also raised the earnings per share forecast for U.S. Bancorp for 2026 from $4.87 to $4.90 [1] Growth Expectations - Stronger loan growth is anticipated due to declining interest rates, stable credit quality, and effective cost management [1]

Core Viewpoint - Leerink Partners has raised the target price for UnitedHealth from $300 to $402, indicating a positive outlook for the company's stock performance [1] Financial Projections - The earnings per share (EPS) forecast for 2026 has been increased from $17.25 to $17.34 [1] - The EPS forecast for 2027 has been raised from $22.34 to $23.62 [1]

Core Viewpoint - Dover Corporation (DOV) expects a revenue growth of 4%-6% for the full year, an increase from the previous forecast of 2%-4% [1] - The company anticipates adjusted earnings per share from continuing operations to be between $9.35 and $9.55, up from the prior estimate of $9.20 to $9.40 [1] Summary by Category - **Revenue Forecast** - Dover Corporation has revised its full-year revenue growth expectation to 4%-6% from an earlier estimate of 2%-4% [1] - **Earnings Per Share (EPS) Guidance** - The company projects adjusted EPS from continuing operations to be in the range of $9.35 to $9.55, an increase from the previous guidance of $9.20 to $9.40 [1]